Bayer introduces medication for chronic kidney disease

"The major focus of therapy in patients with chronic kidney disease and diabetes is to prevent end-stage renal disease or kidney failure. Despite therapy, these patients often progress to kidney failure.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/r2ST4f0
via IFTTT